A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?

Alessandro Leonetti, Daniela Carbone, Alessandro Gregori, Marcello Tiseo, Godefridus J. Peters, Dongmei Deng, Elisa Giovannetti*

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)3135-3137
Number of pages3
JournalJournal of Cancer Research and Clinical Oncology
Issue number10
Early online date2021
Publication statusPublished - Oct 2021

Cite this